Publications by authors named "Angela Minassian"

Claim this Profile
D
Diagnosis of Plasmodium falciparum malaria at very low parasitaemias using a commercially available LAMP assay and RDT.
Ruth O Payne, Nick J Edwards, Yrene Themistocleous, Sarah E Silk, Jordan R Barrett, Angela M Minassian

Trans R Soc Trop Med Hyg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.
Rossa Brugha, Amanda Kirkham, Jessica Bate, G A Amos Burke, Ana Hughes, Angela M Minassian

J Pediatr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.
Leila Janani, Alasdair P S Munro, Annie Wright, Parvinder K Aley, Gavin Babbage, Angela M Minassian

J Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Mimi M Hou, Adam C Harding, Natalie M Barber, Prasun Kundu, Florian A Bach, Angela M Minassian

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection.
Diana Muñoz Sandoval, Florian A Bach, Alasdair Ivens, Adam C Harding, Natasha L Smith, Angela M Minassian

J Exp Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.
Hamtandi M Natama, Jo Salkeld, Athanase Somé, Seyi Soremekun, Salou Diallo, Angela M Minassian

Lancet Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.
Navin Venkatraman, Daniel Silman, Duncan Bellamy, Lisa Stockdale, Georgina Bowyer, Angela M Minassian

Lancet Microbe· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malaria: Past, present and future.
Jo Salkeld, Andrew Duncan, Angela M Minassian

Clin Med (Lond)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, Ivanny M Mtaka, Saumu Ahmed, Angela M Minassian

Lancet Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Jordan R Barrett, Dimitra Pipini, Nathan D Wright, Andrew J R Cooper, Giacomo Gorini, Angela M Minassian

Cell· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.
Lawrence T Wang, Andrew J R Cooper, Brendan Farrell, Kazutoyo Miura, Ababacar Diouf, Angela M Minassian

Cell· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
Lloyd D W King, David Pulido, Jordan R Barrett, Hannah Davies, Doris Quinkert, Angela M Minassian

Cell Rep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
Jonas E Mertens, Cassandra A Rigby, Martino Bardelli, Doris Quinkert, Mimi M Hou, Angela M Minassian

Vaccine· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Jordan R Barrett, Sarah E Silk, Catherine G Mkindi, Karolina M Kwiatkowska, Mimi M Hou, Angela M Minassian

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Francisco J Martinez, Michael White, Micheline Guillotte-Blisnick, Christèle Huon, Alix Boucharlat, Angela M Minassian

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Olivia Bird, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Angela M Minassian

Epidemiol Infect· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Sarah E Silk, Wilmina F Kalinga, Ivanny M Mtaka, Nasoro S Lilolime, Maximillian Mpina, Angela M Minassian

Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic analysis of the human immune response to Plasmodium vivax.
Florian A Bach, Diana Muñoz Sandoval, Michalina Mazurczyk, Yrene Themistocleous, Thomas A Rawlinson, Angela M Minassian

J Clin Invest· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Eimear Kelly, Melanie Greenland, Philip C S de Whalley, Parvinder K Aley, Emma L Plested, Angela M Minassian

J Infect· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.
Xinxue Liu, Alasdair P S Munro, Annie Wright, Shuo Feng, Leila Janani, Angela M Minassian

J Infect· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Mimi M Hou, Jordan R Barrett, Yrene Themistocleous, Thomas A Rawlinson, Ababacar Diouf, Angela M Minassian

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Xinxue Liu, Alasdair Ps Munro, Shuo Feng, Leila Janani, Parvinder K Aley, Angela M Minassian

J Infect· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Kazutoyo Miura, Ababacar Diouf, Michael P Fay, Jordan R Barrett, Ruth O Payne, Angela M Minassian

Malar J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of human malaria infection models for vaccine development.
Wanlapa Roobsoong, Anjali Yadava, Simon J Draper, Angela M Minassian, Jetsumon Sattabongkot

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.
Carolyn M Nielsen, Jordan R Barrett, Christine Davis, Jonathan K Fallon, Cyndi Goh, Angela M Minassian

JCI Insight· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis